Perfluorooctane sulfonate (PFOS) can alter the hypothalamic-pituitary-adrenal (HPA) axis activity by modifying CRF1 and glucocorticoid receptors - Salgado-Freiría, R; López-Doval, S; Lafuente, A (Toxicol Lett, 2018)